Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Gees

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Current Biology : CB|February 15, 2011
The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oilWouter Everaerts, Maarten Gees, Yeranddy A Alpizar, et al.
Nature Neuroscience|September 15, 2009
Nicotine activates the chemosensory cation channel TRPA1Karel Talavera, Maarten Gees, Yuji Karashima, et al.
Pain|April 13, 2011
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulationRomina Nassini, Maarten Gees, Selena Harrison, et al.
Journal of Medicinal Chemistry|September 14, 2021
Correction to "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis"Steven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Frontiers in Pharmacology|May 31, 2019
Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR ModulatorsGert de Wilde, Maarten Gees, Sara Musch, et al.
Frontiers in Pharmacology|November 13, 2018
Identification and Characterization of Novel CFTR PotentiatorsMaarten Gees, Sara Musch, Steven Van der Plas, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic FibrosisSteven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry|November 18, 2017
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High ExtentSteven E Van der Plas, Hans Kelgtermans, Tom De Munck, et al.
Journal of Medicinal Chemistry|March 25, 2024
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-correctorMathieu Pizzonero, Rhalid Akkari, Xavier Bock, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Current Biology : CB|February 15, 2011
The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oilWouter Everaerts, Maarten Gees, Yeranddy A Alpizar, et al.
Nature Neuroscience|September 15, 2009
Nicotine activates the chemosensory cation channel TRPA1Karel Talavera, Maarten Gees, Yuji Karashima, et al.
Pain|April 13, 2011
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulationRomina Nassini, Maarten Gees, Selena Harrison, et al.
Journal of Medicinal Chemistry|September 14, 2021
Correction to "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis"Steven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Frontiers in Pharmacology|May 31, 2019
Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR ModulatorsGert de Wilde, Maarten Gees, Sara Musch, et al.
Frontiers in Pharmacology|November 13, 2018
Identification and Characterization of Novel CFTR PotentiatorsMaarten Gees, Sara Musch, Steven Van der Plas, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic FibrosisSteven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry|November 18, 2017
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High ExtentSteven E Van der Plas, Hans Kelgtermans, Tom De Munck, et al.
Journal of Medicinal Chemistry|March 25, 2024
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-correctorMathieu Pizzonero, Rhalid Akkari, Xavier Bock, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 2